彩票大全app Life Sciences and denovoMATRIX Announce Collaboration to Optimize New Product Development

彩票大全app Life Sciences and denovoMATRIX Announce Collaboration to Optimize New Product Development
November 9, 2021 By Cade Hildreth (CEO)

德累斯顿, 德国, 11月9日, 2021 / BioInformant / — denovoMATRIX GmbH and 彩票大全app Life Sciences have entered into a Master Service Agreement focused on optimizing the performance of new products in development for adherent cell culture and harvest for autologous therapies. The relationship will further explore the synergy of consumable products from both parties and their positive effects for the therapeutic market.

德扬胡锦涛š男人, CEO of denovoMATRIX, commented “Integration of the latest technological innovations in the 细胞疗法 space is essential to bring therapies to clinical trials and the mainstream as soon as possible. We are delighted to partner with 彩票大全app Life Sciences to bring our technology platform to bear on the most critical challenges in autologous cell manufacturing.”

“We have found that the user experience is just as important as the product performance in new product development,” said Benjamin Le Quere, General Manager for 彩票大全app Life Sciences’ Bioprocess Solutions Business Unit. “denovoMatrix is an ideal partner for us because of the technical capabilities they bring to this partnership. The feedback we receive from them will help ensure that our products are achieving the desired results, while being user-friendly for our customers.”

The companies expect to utilize both research and development and laboratory facilities from both companies, including in the United States and 德国. The companies will begin collaborating immediately.

About denovoMATRIX GmbH
denovoMATRIX is an extracellular matrix engineering company that enables the acceleration of cell-based therapies and development in stem cell research. The company leverages chemical synthesis, stem cell biology and design thinking to build a platform of biomaterials which address major life science challenges. By providing both cell-based therapy companies and translational researchers with solutions, denovoMATRIX is at the forefront of innovation in biomaterials.

For more information, visit: http://www.denovomatrix.com/
 

联系人:
denovoMATRIX GmbH
Dr. 德扬胡锦涛š男人 Tatzberg 47/49
01307年德累斯顿
mail@denovomatrix.com

About 彩票大全app Life Sciences

Dedicated to improving the quality of life, 彩票大全app Life Sciences develops and manufactures high-performance components and integrated solutions that touch a broad range of patient care, from the development of new therapeutic cancer treatments to biopharmaceutical production, on through to intravenous therapies for drug delivery. Combining our technical expertise, global manufacturing capabilities and research and development resources, 彩票大全app Life Sciences is dedicated to meeting the evolving needs of bioprocess, medical and pharmaceutical customers around the world.

彩票大全app Life Sciences is part of 彩票大全app Group, 设计, manufactures and distributes materials and solutions for the construction, 流动性, healthcare and other industrial application markets.

€38.1 billion in sales in 2020 More than 167,000名员工, located in 70 countries Committed to achieving Carbon Neutrality by 2050

For more information, www.彩票大全app.com

和访问: http://www.celltherapy.SAINT-GOBAIN.com

联系人:
彩票大全app Life Sciences
凯蒂Oroszi
Marketing Communications Manager
凯蒂.oroszi@彩票大全app.com